Novoron Bioscience Alternatives & Competitors
12 companies similar to Novoron Bioscience — Pioneering lipoprotein-receptor drug development to repair damage and degenerati...
Companies similar to Novoron Bioscience
ReNetX Bio
Pioneering therapeutics to address injuries and damages in the central nervous system, inc...
New Haven, United States
Hemera Pharma
A University of Verona and Milan spin-offs specialized in regenerative medicine for neurol...
Verona, Italy
Umecrine Cognition AB
A novel and safe approach for treating cognitive disorders
Solna, Sweden
Disarm Therapeutics
Creating advanced therapeutics to combat axonal degeneration and treat neurological diseas...
Rival Readout
Competing with Novoron Bioscience? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Vertero Therapeutics, Inc.
Pioneering science beyond the brain to treat neurodegenerative diseases at their source
Woburn, United States
Axerion Therapeutics
Pioneering breakthrough therapies for Alzheimer's and spinal cord injuries through advance...
BrainCells
Pioneering biopharmaceutical solutions to enhance neuron growth and address CNS disorders...
Longboard Pharmaceuticals
We Are Committed To Transforming the Lives of Patients With Neurological and Rare Diseases...
La Jolla, United States
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Vistagen
Changing the trajectory of mental health care – One Mind at a Time
South San Francisco, Unit...
Luxna Biotech Co., Ltd.
Advancing Antisense Therapeutics: Preclinical-stage ASO developer leveraging proprietary X...
Suita, Japan
Sudo Biosciences
Developing precision TYK2 therapeutics.
Carmel, United States
About Novoron Bioscience
Novoron Bioscience is carving a niche in the biotechnology sector by pioneering a novel approach to drug development focused on repairing neurological damage. Their innovative work with lipoprotein-receptor drugs targets severe conditions like multiple sclerosis, spinal cord injuries, and Alzheimer's disease. Founded i...
Development of innovative therapies, Maximized therapeutic benefit exploration, Discovery and development of new drug modalities
Patients with brain and spinal cord injuries, Individuals experiencing neurodegeneration, Healthcare providers and researchers in neurology
Lipoprotein-receptor Drug Development, Neurological Condition Treatment, Central Nervous System Therapeutics, Multiple Sclerosis Research, Spinal Cord Injury Treatment, Alzheimer's Disease Therapy, Neuronal Regeneration, Remyelination Techniques, Orphan Drug Development, Demyelinating Conditions, Tauopathy Solutions, Neuroscience Innovation, CNS Pathologies
B2B, B2D
Licensing, Product Sales, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Novoron Bioscience: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Novoron Bioscience on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
